16.38
price up icon2.44%   0.39
after-market アフターアワーズ: 16.38
loading
前日終値:
$15.99
開ける:
$16.21
24時間の取引高:
4.00M
Relative Volume:
1.76
時価総額:
$1.40B
収益:
$139.71M
当期純損益:
$-209.36M
株価収益率:
-5.5338
EPS:
-2.96
ネットキャッシュフロー:
$-160.60M
1週間 パフォーマンス:
+9.79%
1か月 パフォーマンス:
+19.82%
6か月 パフォーマンス:
-19.39%
1年 パフォーマンス:
-26.32%
1日の値動き範囲:
Value
$16.12
$16.95
1週間の範囲:
Value
$14.53
$16.95
52週間の値動き範囲:
Value
$12.06
$25.34

Syndax Pharmaceuticals Inc Stock (SNDX) Company Profile

Name
名前
Syndax Pharmaceuticals Inc
Name
セクター
Healthcare (1169)
Name
電話
781-419-1400
Name
住所
35 GATEHOUSE DRIVE, WALTHAM, MA
Name
職員
184
Name
Twitter
@syndax
Name
次回の収益日
2024-11-05
Name
最新のSEC提出書
Name
SNDX's Discussions on Twitter

SNDX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
SNDX
Syndax Pharmaceuticals Inc
16.38 1.40B 139.71M -209.36M -160.60M -2.96
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.24 124.35B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
700.33 76.56B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
644.48 39.16B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
250.59 32.44B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
BNTX
Biontech Se Adr
120.01 28.77B 3.30B -501.07M 1.03B -2.1146

Syndax Pharmaceuticals Inc Stock (SNDX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-10-24 開始されました UBS Buy
2024-06-28 開始されました Jefferies Buy
2024-01-31 ダウングレード Scotiabank Sector Outperform → Sector Perform
2023-12-22 開始されました Mizuho Buy
2023-10-25 開始されました BofA Securities Buy
2023-10-11 開始されました Goldman Buy
2023-07-27 開始されました Scotiabank Sector Outperform
2023-07-11 開始されました Guggenheim Buy
2023-04-17 再開されました BTIG Research Buy
2023-01-31 開始されました Stifel Buy
2023-01-03 開始されました JP Morgan Overweight
2022-07-28 再開されました B. Riley Securities Buy
2022-04-11 開始されました H.C. Wainwright Buy
2022-02-15 開始されました Goldman Buy
2021-06-04 再開されました Robert W. Baird Outperform
2021-05-25 開始されました Citigroup Buy
2021-02-18 開始されました B. Riley Securities Buy
2020-12-03 開始されました Stifel Buy
2020-05-22 アップグレード Citigroup Neutral → Buy
2020-05-22 ダウングレード H.C. Wainwright Buy → Neutral
2020-05-18 ダウングレード Citigroup Buy → Neutral
2020-05-11 繰り返されました H.C. Wainwright Buy
2020-03-04 開始されました Barclays Overweight
2020-01-13 繰り返されました H.C. Wainwright Buy
2019-03-08 繰り返されました H.C. Wainwright Buy
2019-01-04 開始されました Robert W. Baird Outperform
2018-01-05 開始されました B. Riley FBR, Inc. Buy
2017-03-16 開始されました FBR & Co. Outperform
2017-03-02 開始されました Instinet Buy
2016-10-07 開始されました Guggenheim Buy
2016-03-28 開始されました Citigroup Buy
2016-03-28 開始されました JMP Securities Mkt Outperform
2016-03-28 開始されました Morgan Stanley Overweight
すべてを表示

Syndax Pharmaceuticals Inc (SNDX) 最新ニュース

pulisher
Feb 21, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Up 6.7%Here's What Happened - MarketBeat

Feb 21, 2025
pulisher
Feb 21, 2025

Should investors be concerned about SNDX’s high price-to-sales ratio? - US Post News

Feb 21, 2025
pulisher
Feb 21, 2025

Syndax Pharmaceuticals (SNDX) Projected to Post Earnings on Tuesday - MarketBeat

Feb 21, 2025
pulisher
Feb 20, 2025

Here's Why We're Watching Syndax Pharmaceuticals' (NASDAQ:SNDX) Cash Burn Situation - Yahoo Finance

Feb 20, 2025
pulisher
Feb 20, 2025

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Feb 20, 2025
pulisher
Feb 19, 2025

When (SNDX) Moves Investors should Listen - Stock Traders Daily

Feb 19, 2025
pulisher
Feb 18, 2025

Syndax Pharmaceuticals' SWOT analysis: stock poised for growth with FDA approvals - Investing.com

Feb 18, 2025
pulisher
Feb 17, 2025

Insider Selling: Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Insider Sells 4,618 Shares of Stock - MarketBeat

Feb 17, 2025
pulisher
Feb 17, 2025

Insider Selling: Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) CFO Sells 3,777 Shares of Stock - MarketBeat

Feb 17, 2025
pulisher
Feb 16, 2025

Michael A. Metzger Sells 13,288 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Stock - MarketBeat

Feb 16, 2025
pulisher
Feb 16, 2025

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World

Feb 16, 2025
pulisher
Feb 15, 2025

Syndax pharmaceuticals CFO Keith Goldan sells $58,558 in stock - MSN

Feb 15, 2025
pulisher
Feb 15, 2025

Don't Ignore The Insider Selling In Syndax Pharmaceuticals - Simply Wall St

Feb 15, 2025
pulisher
Feb 14, 2025

abrdn plc Takes Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

Feb 14, 2025
pulisher
Feb 13, 2025

Syndax pharmaceuticals CFO sells $58,558 in stock - MSN

Feb 13, 2025
pulisher
Feb 12, 2025

Syndax Pharmaceuticals CEO sells $206,017 in shares - MSN

Feb 12, 2025
pulisher
Feb 12, 2025

Syndax pharmaceuticals CFO Keith Goldan sells $58,558 in stock By Investing.com - Investing.com Australia

Feb 12, 2025
pulisher
Feb 12, 2025

Syndax pharmaceuticals CFO sells $58,558 in stock By Investing.com - Investing.com Nigeria

Feb 12, 2025
pulisher
Feb 12, 2025

Syndax Pharmaceuticals CEO sells $206,017 in shares By Investing.com - Investing.com South Africa

Feb 12, 2025
pulisher
Feb 12, 2025

Syndax Pharmaceuticals Executives Sell Shares for Tax Obligations - TradingView

Feb 12, 2025
pulisher
Feb 11, 2025

Is Syndax Pharmaceuticals Inc (SNDX) positioned for future growth? - SETE News

Feb 11, 2025
pulisher
Feb 11, 2025

2 ‘Strong Buy’ Growth Stocks Poised For 141% To 193% Gains, According To Wall Street - Barchart

Feb 11, 2025
pulisher
Feb 11, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Shares Gap UpShould You Buy? - MarketBeat

Feb 11, 2025
pulisher
Feb 10, 2025

Kuehn Law Encourages Investors of Syndax Pharmaceuticals, Inc. to Contact Law Firm - GlobeNewswire Inc.

Feb 10, 2025
pulisher
Feb 08, 2025

Learn to Evaluate (SNDX) using the Charts - Stock Traders Daily

Feb 08, 2025
pulisher
Feb 07, 2025

Syndax Pharmaceuticals Inc [SNDX] stock for 25,037 USD was acquired by Goldan Keith A. - Knox Daily

Feb 07, 2025
pulisher
Feb 07, 2025

Syndax Pharmaceuticals Inc (SNDX) deserves deeper analysis - US Post News

Feb 07, 2025
pulisher
Feb 06, 2025

Kura Oncology falls despite trial success; rival Syndax gains - Seeking Alpha

Feb 06, 2025
pulisher
Feb 06, 2025

Can Syndax Pharmaceuticals Inc Bounce Back? 52-Week Performance and Analyst Predictions - The InvestChronicle

Feb 06, 2025
pulisher
Feb 04, 2025

Syndax Expands Team: Strategic Stock Options Grant Signals Major Growth Phase - StockTitan

Feb 04, 2025
pulisher
Feb 04, 2025

Ready to Jump After Recent Trade: Syndax Pharmaceuticals Inc (SNDX) - SETE News

Feb 04, 2025
pulisher
Feb 04, 2025

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Yahoo Finance

Feb 04, 2025
pulisher
Jan 30, 2025

Syndax Leadership Reveals Growth Strategy at Elite Healthcare Investment Forums - StockTitan

Jan 30, 2025
pulisher
Jan 30, 2025

Syndax Announces Participation in February Investor Conferences - Yahoo Finance

Jan 30, 2025
pulisher
Jan 28, 2025

(SNDX) Investment Analysis and Advice - Stock Traders Daily

Jan 28, 2025
pulisher
Jan 23, 2025

Incyte and Syndax to scale Niktimvo production after FDA approval - BioProcess Insider

Jan 23, 2025

Syndax Pharmaceuticals Inc (SNDX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$33.42
price up icon 0.27%
$81.06
price down icon 3.05%
$361.10
price down icon 1.70%
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
$120.01
price up icon 1.81%
大文字化:     |  ボリューム (24 時間):